about
Virtual Screening for Potential Inhibitors of NS3 Protein of Zika VirusStructural Studies of the HIV-1 Integrase Protein: Compound Screening and Characterization of a DNA-Binding InhibitorA Novel Phenanthridionone Based Scaffold As a Potential Inhibitor of the BRD2 Bromodomain: Crystal Structure of the ComplexOpen source molecular modelingA molecular modeling based screening for potential inhibitors to alpha hemolysin from Staphylococcus aureusRapid Detection of Avian Influenza Virus by Fluorescent Diagnostic Assay using an Epitope-Derived Peptide.Molecular docking based screening of predicted potential inhibitors for VP40 from Ebola virus.JAK3 inhibitor VI is a mutant specific inhibitor for epidermal growth factor receptor with the gatekeeper mutation T790M.Allosteric inhibitors of Coxsackie virus A24 RNA polymeraseNovel Anthra[1,2-c][1,2,5]Thiadiazole-6,11-Diones as Promising Anticancer Lead Compounds: Biological Evaluation, Characterization & Molecular Targets DeterminationA Large and Phylogenetically Diverse Class of Type 1 Opsins Lacking a Canonical Retinal Binding SiteMolecular docking based virtual screening of compounds for inhibiting sortase A in L.monocytogenes.The Response Regulator BfmR Is a Potential Drug Target for Acinetobacter baumannii.Flurbiprofen-antioxidant mutual prodrugs as safer nonsteroidal anti-inflammatory drugs: synthesis, pharmacological investigation, and computational molecular modeling.Synthesis, Bioevaluation and Molecular Dynamic Simulation Studies of Dexibuprofen-Antioxidant Mutual Prodrugs.In silico identification of potential drug compound against Peroxisome proliferator-activated receptor-gamma by virtual screening and toxicity studies for the treatment of Diabetic Nephropathy.Peptide aptamer identified by molecular docking targeting translationally controlled tumor protein in leukemia cells.Simulation and Comparative Analysis of Different Binding Modes of Non-nucleoside Agonists at the A2A Adenosine Receptor.Exploration of Novel Human Tyrosinase Inhibitors by Molecular Modeling, Docking and Simulation Studies.The Length and Flexibility of the 2-Substituent of 9-Ethyladenine Derivatives Modulate Affinity and Selectivity for the Human A2A Adenosine Receptor.Molecular docking based screening of Listeriolysin-O for improved inhibitors.Competitive rational inhibitor design to 4-maleylaceto-acetate isomerase.Molecular docking analysis of nitisinone with homogentisate 1,2 dioxygenase.Development of highly potent melanogenesis inhibitor by in vitro, in vivo and computational studies.Revealing the potency of Annona muricata leaves extract as FOXO1 inhibitor for diabetes mellitus treatment through computational study.Molecular characterization, modeling, in silico analysis of equine pituitary gonadotropin alpha subunit and docking interaction studies with ganirelixA Novel Class of Dopamine D4 Receptor Ligands Bearing an Imidazoline Nucleus.Computational approaches to the in vitro antibacterial activity of Allium hirtifolium Boiss against gentamicin-resistant Escherichia coli: focus on ribosome recycling factor.Modeling, molecular docking, probing catalytic binding mode of acetyl-CoA malate synthase G in Brucella melitensis 16M.Molecular structure-function relationship of dietary polyphenols for inhibiting VEGF-induced VEGFR-2 activityVirtual screening following rational drug design based approach for introducing new anti amyloid beta aggregation agentIn vitro and in silico interaction of porcine α-amylase with Vicia faba crude seed extract and evaluation of antidiabetic activity.Beauvericin counteracted multi-drug resistant Candida albicans by blocking ABC transporters.Structural basis of small molecule ATPase inhibition of a human mitotic kinesin motor protein.Multidrug resistance-associated protein 4 is a bile transporter of Clonorchis sinensis simulated by in silico docking.Providing sustained transgene induction through affinity-based drug delivery.Small Molecule Enhancement of 20S Proteasome Activity Targets Intrinsically Disordered Proteins.Structural Probing, Screening and Structure-Based Drug Repositioning Insights into the Identification of Potential Cox-2 Inhibitors from Selective Coxibs.In Vitro, In Silico Elucidation of Antiurease Activity, Kinetic Mechanism and COX-2 Inhibitory Efficacy of Coagulansin A of Withania coagulans.Synthesis, enzyme inhibitory kinetics, and computational studies of novel 1-(2-(4-isobutylphenyl) propanoyl)-3-arylthioureas as Jack bean urease inhibitors.
P2860
Q27468584-2C3E4D99-0392-4CB9-8DF0-4B4211531D28Q28547968-A15148F4-3C00-4AFA-B7A0-832DDD9EFEEEQ28552504-F4A41573-8CA7-4BDA-83BD-8884B7CA111FQ28598346-D1F7EC67-81ED-4411-995D-E5F3D56888D1Q33426334-F26346C4-5FF7-44B4-84EA-96DCBA7D5812Q33820978-1F80265B-B08C-4C80-8A27-96A695AF4896Q35678240-946E7608-3840-43AF-B82E-81941FEA7449Q35858399-17760F13-55E3-433C-9499-5AE2D418CD7CQ35893201-4C069166-37C7-4D15-AE30-B52B56D6FC74Q35996034-C5022F3B-4373-4753-8C4D-2ECB21126EB5Q36057851-F4152DBC-12A9-4802-8AE5-8F04884F42E1Q36564369-C35B0682-1574-426A-8503-2DD335DDDE83Q36956080-0FF78789-076A-487A-8E3D-8A783D596FB8Q37143003-1579233F-5A51-4FCB-A0E9-13F99804EF86Q37534991-E3D30603-10F5-4988-B7E6-31709DD46770Q38370634-FD03BA02-FD42-47D1-B7C0-A3640B8A75E1Q38786718-FD740EF2-BA1E-4E4D-87E1-B5E889C80244Q39469198-36640DF0-5907-4CD1-86F8-25DE9E17558AQ39835668-808DD092-1780-49ED-824C-F7247D96C7A1Q39870318-BDF80BE7-2F3D-4E5B-AB27-252BC12E586BQ40955927-2CE8D334-0440-4088-92B7-452F2DBD571DQ40955945-74F94F6A-06B2-40A3-B4AC-1C9FE4797977Q40955953-DF421131-82DD-4EE1-8B81-A0A92BB26A1EQ40970657-45BFC87E-E56C-4F3E-AE17-97508CBC8250Q41042360-82F40275-00C8-4A39-B085-37F7F3E26D9DQ41049644-F7F8E8AF-E18C-45C6-8D78-5CB00EA7930DQ41444993-7BC0474F-FC5D-4A33-B43D-C3CB60FE5281Q41566163-E7F30F01-ED96-445E-BFB4-0B47D868E811Q41682682-E5B43837-FA7B-49A7-AE76-2373FD80C3EEQ41849029-4C41FD19-6413-41A3-AE06-985EC8AE8066Q42214607-9EDC9FD6-B5F7-445B-893B-70A9E68E568AQ42536876-90CB1E3B-EC38-47CB-8B81-EE86E39F0BF8Q44606676-B557097D-02F2-4952-85A3-D3BF26912A20Q44722786-2E018C01-8C50-4513-99B7-BC6C3C072779Q45418018-5C8AA626-D806-44A3-8AC0-AEE171EDB302Q45882136-E474CBBF-B8CC-43DD-A453-97330D739796Q47141859-36AE1049-6BC3-4975-98C0-3154DFF429C0Q47298451-C1DA7B1D-C3ED-4C29-920F-BF056EE5ADEDQ47420890-824937BA-71FA-4AA7-B44C-1076AC04DD7EQ48188132-73A6965C-22F9-440E-891E-18971B6C21E7
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Small-molecule library screening by docking with PyRx.
@ast
Small-molecule library screening by docking with PyRx.
@en
type
label
Small-molecule library screening by docking with PyRx.
@ast
Small-molecule library screening by docking with PyRx.
@en
prefLabel
Small-molecule library screening by docking with PyRx.
@ast
Small-molecule library screening by docking with PyRx.
@en
P1476
Small-molecule library screening by docking with PyRx.
@en
P2093
Arthur J Olson
Sargis Dallakyan
P304
P356
10.1007/978-1-4939-2269-7_19
P407
P577
2015-01-01T00:00:00Z